Thompson Davis & Co’s Select Medical SEM Stock Holding History

Thompson Davis & Co’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-464	Closed	-$3K	–	1225
2016 Q4	$3K	Buy	+464	New	+$3.23K	0.01%	977

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's SEM Position: Q1 2017 in Review

Thompson Davis & Co sold out of Select Medical (SEM) in Q1 2017, closing a stake of 464 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in SEM in Q4 2016 and held it in 1 quarter. The position peaked at $3K in Q4 2016. 164 funds tracked by Wall St. Rank hold SEM as of Q1 2017.

Thompson Davis & Co reported no remaining Select Medical position as of Q1 2017 after selling out during the quarter.
Thompson Davis & Co sold 464 Select Medical shares in Q1 2017, an estimated $3K.
Thompson Davis & Co first reported a position in Select Medical in Q4 2016 and held it in 1 quarter.
Thompson Davis & Co's Select Medical position peaked at $3K in Q4 2016.
164 funds tracked by Wall St. Rank held Select Medical as of Q1 2017.

Based on Thompson Davis & Co's 13F filing for Q1 2017, filed 8 May 2017.